Collin M. Blakely

Department of Medicine,
Helen Diller Family Comprehensive Cancer Center

BIOGRAPHY

Collin M. Blakely has not added Biography.

If you are Collin M. Blakely and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.

Clinical lung cancer 03, 2019 | Pubmed ID: 30553716

Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research 01, 2020 | Pubmed ID: 31548343

A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations.

Clinical cancer research : an official journal of the American Association for Cancer Research 12, 2019 | Pubmed ID: 31611281

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.

Cell 09, 2020 | Pubmed ID: 32822576

INSTITUTIONS

University of California, San Francisco

JOVE ARTICLES

Dora Barbosa Rabago^1,2,3,

Collin M. Blakely^1,2,

Franziska Haderk^1,2,3,

Trever G. Bivona^1,2,3

¹Department of Medicine, University of California, San Francisco,

²Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,

³Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE